Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2005
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234034 One of the ring nitrogens is carbonyl-substituted, e.g., 2-(4-Chloro-5-methyl-3-trifluoromethyl-pyrazol-1-yl)-1-[5-(2,4-dichloro-benzyl)-hexahydropyrrolo[3,4-c]pyrrol-2-yl]ethanone; inflammatory disorders (rheumatoid arthritis, multiple sclerosis)and immune disorders (transplant rejection)
10/20/2005CA2567574A1 Benzotriazine inhibitors of kinases
10/20/2005CA2562780A1 Nucleic acid melting analysis with saturation dyes
10/20/2005CA2561801A1 Sulfonamides and uses thereof
10/20/2005CA2561203A1 New process for the preparation of diazine derivatives
10/20/2005CA2560954A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005CA2560796A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005CA2560314A1 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/20/2005CA2560162A1 Inhibitors of iap
10/20/2005CA2557721A1 Ion channel modulators
10/19/2005EP1586571A1 Dipeptidyl peptidase inhibitors
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585744A1 Process for making ondansetron and intermediates thereof
10/19/2005EP1585743A1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
10/19/2005EP1585737A2 Uracils having a herbicidal activity
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585728A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
10/19/2005EP1585727A1 Indoles useful in the treatment of androgen-receptor related diseases
10/19/2005EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/19/2005EP1102752B1 Succinoylamino lactams as inhibitors of a beta protein production
10/19/2005EP1070714A9 Amidine compounds
10/19/2005CN1684960A Delta1 pyrrolines used as pesticides
10/19/2005CN1684955A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/19/2005CN1684953A 吡唑化合物 Pyrazole compounds
10/19/2005CN1683344A 4-quinazolone derivative and its use in anti-tumor medicine
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223587C Process for producing substituted aniline compound
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956988 Optical interleaver
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956039 Nitrogenous heterocylic compounds
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2190129C Therapeutic phenoxyalkylpyridazines and intermediates therefor
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/18/2005CA2117511C N-cyanoaryl-nitrogen heterocycles
10/18/2005CA2046265C Sulphured imadazole derivatives, their preparation process, the new intermediates obtained, their application as drugs and the pharmaceutical preparations containing them
10/13/2005WO2005095407A1 M3 muscarinic acetylcholine receptor antagonists
10/13/2005WO2005095406A1 Compositions useful as inhibitors of protein kinases
10/13/2005WO2005095392A1 Silylated carboxamides
10/13/2005WO2005095389A1 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095353A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005WO2005095350A1 Pyrazole compounds and uses related thereto
10/13/2005WO2005095345A2 Heteroaryl guanidines as inhibitors of viral replication
10/13/2005WO2005095339A1 Dicyanopyrrolidines as dipeptidyl peptidase iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094828A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2005068468A3 Heterocyclic protein kinase inhibitors and uses thereof
10/13/2005WO2005067644A3 Conjugated small molecules
10/13/2005WO2005041867A3 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3’(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrozol-3-one choline
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005WO2004071447A9 Substituted azole derivatives as therapeutic agents
10/13/2005US20050228184 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
10/13/2005US20050228182 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, prolonged pharmacodynamic half-life; chronic bronchitis, cystic fibrosis, sinusitis, dry eye, mucus clearance
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050228179 Thionation of a carbonyl compound comprising a nitrile group, the presence of a decoy agent comprising a nitrile group
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228034 treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease; for treating, ameliorating or preventing a CB1 receptor inverse-agonist mediated appetite related obesity related or metabolism related syndrome, disorder or disease
10/13/2005US20050228000 of the coagulation cascade or contact activation system: thrombin, factor Xa, factor XIa, factor IXa, factor VIIa or plasma kallikrein; e.g. -(6-carbamimidoyl-1H-indol-3-ylmethyl)-4-methoxy-biphenyl-2-carboxylic acid; anticoagulant, antiinflammatory agent
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227971 Thioamide derivatives as progesterone receptor modulators
10/13/2005US20050227965 Crystalline polymorph of bazedoxifene acetate
10/13/2005US20050227960 N-[(octahydrocyclopenta[c] pyrrol-5-ylcarbamoyl)methyl]-3 -trifluoromethylbenzamide trifluoroacetic acid salt; monocyte chemotactic proteins (MCP-1) receptor antagonist or partial agonists; antiinflammatory agent, antiallergen, autoimmune diseases; rheumatoid arthritis, atherosclerosis, asthma
10/13/2005US20050227076 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005US20050224524 Aerosol
10/13/2005DE10393799T5 Kinaseinhibitoren für die Behandlung von Erkrankungen Kinase inhibitors for the treatment of diseases
10/13/2005DE102004015007A1 Substituierte Imidazole Substituted imidazoles
10/13/2005DE102004014945A1 Prolinylderivate Prolinylderivate
10/13/2005DE102004010194A1 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln 4-benzimidazole-2-yl-pyridazin-3-one derivatives, their preparation and use in medicaments
10/13/2005CA2563038A1 Neurologically-active compounds
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2561305A1 Tetrahydro-indazole cannabinoid modulators
10/13/2005CA2559957A1 Silylated carboxamides
10/13/2005CA2559945A1 Pyrazole compounds and uses related thereto
10/13/2005CA2558915A1 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005CA2557719A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005CA2557372A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005CA2554551A1 Compositions useful as inhibitors of protein kinases
10/12/2005EP1583763A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583534A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/12/2005EP1583528A1 Nf-kb inhibitors and uses thereof
10/12/2005EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
10/12/2005EP1177188B1 Pyrazole carboxamides useful for the treatment of obesity and other disorders
1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 626